These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19855156)

  • 1. Taking aim at novel vaccines market.
    Awasthi S
    Hum Vaccin; 2009 Oct; 5(10):654-7. PubMed ID: 19855156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's emerging vaccine industry.
    Hendriks J; Liang Y; Zeng B
    Hum Vaccin; 2010 Jul; 6(7):602-7. PubMed ID: 20523120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The U.S. vaccine and immunization enterprise: Working to sustain and foster vaccine innovation.
    Shen AK
    Hum Vaccin; 2009 Oct; 5(10):649-53. PubMed ID: 19713758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting biodefense markets.
    Olinger GG
    Hum Vaccin; 2009 Oct; 5(10):660-5. PubMed ID: 19855169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How will diagnostics create new opportunities for prophylactic and therapeutic vaccines?: 2011 Phacilitate Vaccine Forum, Washington DC Day 2, afternoon plenary session—January 25, 2011.
    Sardesai NY
    Hum Vaccin; 2011 Jun; 7(6):607-9. PubMed ID: 21602621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation of human vaccines: what does the future hold?
    Awasthi S
    Hum Vaccin; 2008; 4(5):344-6. PubMed ID: 18849649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6th Annual Vaccines: all things considered.
    Chen W; Kuolee R
    Expert Rev Vaccines; 2009 Mar; 8(3):281-4. PubMed ID: 19249968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines, our shared responsibility.
    Pagliusi S; Jain R; Suri RK;
    Vaccine; 2015 May; 33(19):2197-2202. PubMed ID: 25749248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual World Vaccine Congress 2014: a re-evaluation of the value proposition for increasing vaccine thermostability.
    Derwand R
    Hum Vaccin Immunother; 2014; 10(10):3087-9. PubMed ID: 25483655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the research-based industry approaches vaccine development and establishes priorities.
    André FE
    Dev Biol (Basel); 2002; 110():25-9. PubMed ID: 12477303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives.
    Cortes Mde L; Cardoso D; Fitzgerald J; DiFabio JL
    Biologicals; 2012 Jan; 40(1):3-14. PubMed ID: 22033155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European strategy for vaccine development against infectious diseases.
    Matthiessen L; Lång H; Klimathianaki M; Hanrahan F; Kerstiëns B; Martini A; Draghia-Akli R
    Vaccine; 2017 Jan; 35 Suppl 1():A20-A23. PubMed ID: 28017443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID).
    Dinleyici EC; Kurugol Z
    Expert Rev Vaccines; 2010 Mar; 9(3):261-72. PubMed ID: 20218854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United States vaccine research: a delicate fabric of public and private collaboration. National Vaccine Advisory Committee.
    Pediatrics; 1997 Dec; 100(6):1015-20. PubMed ID: 9411380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial lessons from public-private partnerships in drug and vaccine development.
    Wheeler C; Berkley S
    Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11th Annual Conference on Vaccine Research.
    O'Brien J
    Expert Rev Vaccines; 2008 Aug; 7(6):721-3. PubMed ID: 18665770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria: the king is threatened.
    Smith NJ
    IDRC Rep; 1985 Jan; 13(4):4-6. PubMed ID: 12281239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second National Immunization Congress 2010: addressing vaccine financing for the future in the US.
    Shen AK; Sobzcyk E; Buchanan A; Wu L; Duggan-Goldstein S
    Hum Vaccin; 2011 Jan; 7(1):12-8. PubMed ID: 21178397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.